The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
122862595 12286259 5 F 20160819 20160420 20160829 PER US-PFIZER INC-2016194973 PFIZER 71.00 YR M Y 77.00000 KG 20160829 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
122862595 12286259 1 PS SUTENT SUNITINIB MALATE 1 50 MG, 2 WEEKS ON/1 WEEK OFF N 21938 50 MG CAPSULE, HARD
122862595 12286259 2 SS SUTENT SUNITINIB MALATE 1 N 21938 CAPSULE, HARD
122862595 12286259 3 C AMLODIPINE AMLODIPINE BESYLATE 1 UNK 0
122862595 12286259 4 C CALCIUM CALCIUM 1 UNK 0
122862595 12286259 5 C OXYCODONE OXYCODONE 1 10 MG, UNK 0 10 MG
122862595 12286259 6 C ZOMETA ZOLEDRONIC ACID 1 UNK 0
122862595 12286259 7 C VITAMIN D CHOLECALCIFEROL 1 UNK 0
122862595 12286259 8 C VITAMIN B COMPLEX CYANOCOBALAMINDEXPANTHENOLNIACINAMIDEPYRIDOXINE HYDROCHLORIDERIBOFLAVIN 5'-PHOSPHATE SODIUMTHIAMINE HYDROCHLORIDEVITAMIN B COMPLEX 1 UNK 0
122862595 12286259 9 C VITAMIN C ASCORBIC ACID 1 UNK 0
122862595 12286259 10 C BETA GLUCAN BETA GLUCAN 1 UNK 0
122862595 12286259 11 C PROBIOTIC COMPLEX 2 UNK 0
122862595 12286259 12 C RESVERATROL RESVERATROL 1 UNK 0
122862595 12286259 13 C SENNATAB 2 UNK 0 TABLET
122862595 12286259 14 C MIRALAX POLYETHYLENE GLYCOL 3350 1 UNK, AS NEEDED 0
122862595 12286259 15 C MELATONIN MELATONIN 1 UNK, AS NEEDED 0
122862595 12286259 16 C PRILOSEC OMEPRAZOLE MAGNESIUM 1 UNK 0
122862595 12286259 17 C NEXIUM ESOMEPRAZOLE MAGNESIUM 1 UNK 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
122862595 12286259 1 Bone cancer
122862595 12286259 2 Metastatic renal cell carcinoma
122862595 12286259 14 Constipation

Outcome of event

Event ID CASEID OUTC COD
122862595 12286259 DE

Reactions reported

Event ID CASEID DRUG REC ACT PT
122862595 12286259 Arthralgia
122862595 12286259 Asthenia
122862595 12286259 Back pain
122862595 12286259 Balance disorder
122862595 12286259 Constipation
122862595 12286259 Decreased appetite
122862595 12286259 Dehydration
122862595 12286259 Disease progression
122862595 12286259 Dysgeusia
122862595 12286259 Dyspepsia
122862595 12286259 Fatigue
122862595 12286259 Gastric disorder
122862595 12286259 Headache
122862595 12286259 Insomnia
122862595 12286259 Listless
122862595 12286259 Metastatic renal cell carcinoma
122862595 12286259 Musculoskeletal pain
122862595 12286259 Nausea
122862595 12286259 Vomiting
122862595 12286259 Weight decreased
122862595 12286259 Weight fluctuation

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
122862595 12286259 1 20160320 0